These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6428140)
1. Deprenyl (selegiline) in the treatment of Parkinson's disease. Birkmayer W Acta Neurol Scand Suppl; 1983; 95():103-5. PubMed ID: 6428140 [TBL] [Abstract][Full Text] [Related]
2. Deprenyl (selegiline) in combination treatment of Parkinson's disease. Gerstenbrand F; Ransmayr G; Poewe W Acta Neurol Scand Suppl; 1983; 95():123-6. PubMed ID: 6428144 [TBL] [Abstract][Full Text] [Related]
3. R-(-)-deprenyl as an adjuvant to levodopa in the treatment of Parkinson's disease. Rinne UK J Neural Transm Suppl; 1987; 25():149-55. PubMed ID: 3123601 [TBL] [Abstract][Full Text] [Related]
5. Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease. Presthus J; Hajba A Acta Neurol Scand Suppl; 1983; 95():127-33. PubMed ID: 6428145 [TBL] [Abstract][Full Text] [Related]
6. Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience. Birkmayer W; Birkmayer GD J Neural Transm Suppl; 1986; 22():219-25. PubMed ID: 3097256 [TBL] [Abstract][Full Text] [Related]
7. Deprenyl (selegiline) in the treatment of Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1983; 95():107-11. PubMed ID: 6428141 [TBL] [Abstract][Full Text] [Related]
8. Selegiline in the treatment of Parkinson's disease. Heinonen EH; Rinne UK Acta Neurol Scand Suppl; 1989; 126():103-11. PubMed ID: 2515715 [TBL] [Abstract][Full Text] [Related]
9. (-)Deprenyl in the treatment of Parkinson's disease. Birkmayer W; Riederer P; Youdim MB Clin Neuropharmacol; 1982; 5(2):195-230. PubMed ID: 6814755 [No Abstract] [Full Text] [Related]
10. R-(-)-deprenyl as a possible protective agent in Parkinson's disease. Tetrud JW; Langston JW J Neural Transm Suppl; 1987; 25():69-79. PubMed ID: 3123606 [TBL] [Abstract][Full Text] [Related]
11. Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa. Schachter M; Marsden CD; Parkes JD; Jenner P; Testa B J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):1016-21. PubMed ID: 6777463 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's disease. Csanda E; Tárczy M Acta Neurol Scand Suppl; 1983; 95():117-22. PubMed ID: 6428143 [TBL] [Abstract][Full Text] [Related]
13. Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients. Elizan TS; Yahr MD; Moros DA; Mendoza MR; Pang S; Bodian CA Arch Neurol; 1989 Dec; 46(12):1280-3. PubMed ID: 2511825 [TBL] [Abstract][Full Text] [Related]
15. Selegiline (1-deprenyl) and low-dose levodopa treatment of Parkinson's disease. A double-blind crossover trial. Presthus J; Berstad J; Lien K Acta Neurol Scand; 1987 Sep; 76(3):200-3. PubMed ID: 3120487 [TBL] [Abstract][Full Text] [Related]
16. Selegiline in the treatment of Parkinson's disease--long term experience. Yahr MD; Elizan TS; Moros D Acta Neurol Scand Suppl; 1989; 126():157-61. PubMed ID: 2515721 [TBL] [Abstract][Full Text] [Related]
17. Combination of a dopamine agonist, MAO-B inhibitor and levodopa--a new strategy in the treatment of early Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1989; 126():165-9. PubMed ID: 2515722 [TBL] [Abstract][Full Text] [Related]
18. L-deprenyl in the treatment of Parkinson's disease. Csanda E; Tárczy M; Takáts A; Mogyorós I; Köves A; Katona G J Neural Transm Suppl; 1983; 19():283-90. PubMed ID: 6421993 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline). Yahr MD; Mendoza MR; Moros D; Bergmann KJ Acta Neurol Scand Suppl; 1983; 95():95-102. PubMed ID: 6428152 [TBL] [Abstract][Full Text] [Related]
20. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Tetrud JW; Langston JW Science; 1989 Aug; 245(4917):519-22. PubMed ID: 2502843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]